Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Discovery of intratumoral oncolytic bacteria toward targeted anticancer theranostics

Yamato Goto, Seigo Iwata, View ORCID ProfileEijiro Miyako
doi: https://doi.org/10.1101/2022.10.25.513676
Yamato Goto
1Graduate School of Advanced Science and Technology, Japan Advanced Institute of Science and Technology, 1-1 Asahidai, Nomi, Ishikawa 923-1292, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seigo Iwata
1Graduate School of Advanced Science and Technology, Japan Advanced Institute of Science and Technology, 1-1 Asahidai, Nomi, Ishikawa 923-1292, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eijiro Miyako
1Graduate School of Advanced Science and Technology, Japan Advanced Institute of Science and Technology, 1-1 Asahidai, Nomi, Ishikawa 923-1292, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eijiro Miyako
  • For correspondence: e-miyako@jaist.ac.jp
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

Abstract

Unveiling the different biomedical functions of tumor-resident microbiota has remained challenging for the development of advanced anticancer medicines. Here we show that isolated intratumoral bacteria with its association with natural purple photosynthetic bacteria have a high innate biocompatibility and drastic immunogenic anticancer efficacies. They preferentially grow and proliferate within targeted tumor milieu, which effectively causes immune cells to infiltrate the tumor and provoke strong anticancer responses in various syngeneic mouse models including those of colorectal cancer, sarcoma, metastatic lung cancer, and extensive drug-resistant breast cancer. Furthermore, these functional bacteria-treated mice, that exhibit excellent anticancerous responses of tumors, have significantly prolonged survival rates with effective immunological memory. Notably, light-harvesting nanocomplexes of microbial consortium of intratumoral bacteria and purple photosynthetic bacteria is capable of tumor diagnosis using bio-optical-window near-infrared light, making them useful theranostic agents for highly targeted immunological elimination of the tumor and for precisely marking tumor location.

Competing Interest Statement

E. M. is inventor of the pending patents that cover a part of key ideas of intratumoral oncolytic bacteria (JP2022/082458 and JP2022/082460, applied by Japan Advanced Institute of Science and Technology). The authors declare no other competing interests.

Footnotes

  • Conflict-of-interest statement E. M. is inventor of the pending patents that cover a part of key ideas of intratumoral oncolytic bacteria (JP2022/082458 and JP2022/082460, applied by Japan Advanced Institute of Science and Technology).

  • The authors declare no other competing interests.

  • The title of manuscript updated.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted November 15, 2022.
Download PDF
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Discovery of intratumoral oncolytic bacteria toward targeted anticancer theranostics
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Discovery of intratumoral oncolytic bacteria toward targeted anticancer theranostics
Yamato Goto, Seigo Iwata, Eijiro Miyako
bioRxiv 2022.10.25.513676; doi: https://doi.org/10.1101/2022.10.25.513676
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Discovery of intratumoral oncolytic bacteria toward targeted anticancer theranostics
Yamato Goto, Seigo Iwata, Eijiro Miyako
bioRxiv 2022.10.25.513676; doi: https://doi.org/10.1101/2022.10.25.513676

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Bioengineering
Subject Areas
All Articles
  • Animal Behavior and Cognition (4095)
  • Biochemistry (8792)
  • Bioengineering (6495)
  • Bioinformatics (23405)
  • Biophysics (11769)
  • Cancer Biology (9173)
  • Cell Biology (13304)
  • Clinical Trials (138)
  • Developmental Biology (7426)
  • Ecology (11392)
  • Epidemiology (2066)
  • Evolutionary Biology (15127)
  • Genetics (10419)
  • Genomics (14029)
  • Immunology (9154)
  • Microbiology (22132)
  • Molecular Biology (8797)
  • Neuroscience (47470)
  • Paleontology (350)
  • Pathology (1423)
  • Pharmacology and Toxicology (2486)
  • Physiology (3712)
  • Plant Biology (8073)
  • Scientific Communication and Education (1434)
  • Synthetic Biology (2217)
  • Systems Biology (6023)
  • Zoology (1251)